JP Morgan Chase
IRD

JP Morgan Chase’s Opus Genetics IRD Stock Holding History

JP Morgan Chase’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58
Closed -$57 – 7802
2025
Q1 		$57 Buy
+58
New +$65 ﹤0.01% 6964
2023
Q4 		– Sell
-8,474
Closed -$28.4K – 7934
2023
Q3 		$28.4K Buy
+8,474
New +$34K ﹤0.01% 5978
2022
Q4 		– Sell
-15,600
Closed -$31K – 7075
2022
Q3 		$31K Buy
+15,600
New +$33.7K ﹤0.01% 5691
2014
Q2 		– Sell
-169
Closed -$88K – 3641
2014
Q1 		$88K Buy
+169
New +$91.4K ﹤0.01% 3492

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase's IRD Position: Q2 2025 in Review

JP Morgan Chase sold out of Opus Genetics (IRD) in Q2 2025, closing a stake of 58 shares — an estimated $57 sold.

JP Morgan Chase first reported a position in IRD in Q1 2014 and held it in 4 quarters. The position peaked at $88K in Q1 2014. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • JP Morgan Chase reported no remaining Opus Genetics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 58 Opus Genetics shares in Q2 2025, an estimated $57.
  • JP Morgan Chase first reported a position in Opus Genetics in Q1 2014 and held it in 4 quarters.
  • JP Morgan Chase's Opus Genetics position peaked at $88K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.